Results 351 to 360 of about 342,446 (410)
Some of the next articles are maybe not open access.
Related searches:
Related searches:
To GERD or not to GERD, this is the question
The Journal of Pediatrics, 2009No abstract ...
TORNESE, GIANLUCA+3 more
openaire +3 more sources
The pharmacotherapeutic management of gastroesophageal reflux disease (GERD)
Expert Opinion on Pharmacotherapy, 2020Introduction Gastroesophageal reflux disease (GERD) is a very common worldwide condition, affecting about 15–20% of the whole population, and representing a major burden for health-care systems.
N. Chapelle+3 more
semanticscholar +1 more source
Nocturnal Gastroesophageal Reflux Disease (GERD) and Sleep
Journal of Clinical Gastroenterology, 2020Gastroesophageal reflux disease (GERD) is a prevalent, chronic medical condition that affects 13% of the adult population globally at least once a week.
Fahmi Shibli+3 more
semanticscholar +1 more source
Gastroenterology Clinics of North America, 2008
The manifestations of gastroesophageal reflux disease (GERD) have been classified into either esophageal or extraesophageal syndromes. Cough, reflux laryngitis, and asthma have been classified as extraesophageal syndromes, whereas reflux chest pain has been classified as a symptomatic syndrome of GERD.
Jeanetta Walters, Frye, Michael F, Vaezi
openaire +2 more sources
The manifestations of gastroesophageal reflux disease (GERD) have been classified into either esophageal or extraesophageal syndromes. Cough, reflux laryngitis, and asthma have been classified as extraesophageal syndromes, whereas reflux chest pain has been classified as a symptomatic syndrome of GERD.
Jeanetta Walters, Frye, Michael F, Vaezi
openaire +2 more sources
Endoscopic treatments for GERD
Annals of the New York Academy of Sciences, 2020AbstractGastroesophageal reflux disease (GERD) is a condition with increasing prevalence and morbidity in the United States and worldwide. Despite advances in medical and surgical therapy over the last 30 years, gaps remain in the therapeutic profile of options.
Dean J. Mikami+5 more
openaire +3 more sources
Endotherapy for and tailored approaches to treating GERD, and refractory GERD
Annals of the New York Academy of Sciences, 2013This paper presents commentaries on how endoluminal antireflux procedures compare to laparoscopic fundoplication; new endoscopic procedures being studied to treat refractory gastroesophageal reflux disease (GERD); the new Stretta; the relationship between obesity and proton pump inhibitor (PPI) resistance; data concerning acid hypersensitivity and ...
G. Richard Locke III+9 more
openaire +4 more sources
Esophageal reflux hypersensitivity: Non-GERD or still GERD?
Digestive and Liver Disease, 2020The most recent iteration of the classifications for functional esophageal disorders, Rome IV, proposed relevant modifications of the previous definitions for Rome III. They specifically considered increased esophageal acid exposure as the marker of gastroesophageal reflux disease (GERD), including the remaining part of non-erosive reflux disease ...
Gaia Pellegatta+9 more
openaire +2 more sources
Gastroesophageal reflux disease (GERD) in children
Paediatrics and International Child Health, 2018Background: Gastro-oesophageal reflux (GER) and gastro-oesophageal reflux disease (GERD) are common in infants and children. Aims: To review the recent literature on GERD in children and to outline the approach to diagnosis and management.
U. Poddar
semanticscholar +1 more source
Relationship between Helicobacter pylori infection and GERD
Acta bio-medica : Atenei Parmensis, 2018Gastroesophageal reflux disease (GERD) is due to the chronic exposure of the esophageal mucosa to acid secretion from the stomach. Helicobacter pylori (H.p.) infection, is a risk factor for the development of peptic ulcer, atrophic gastritis and gastric ...
Scida Serena+7 more
semanticscholar +1 more source